UNCLAIMED
Agios
Overview
Agios Pharmaceuticals, Inc. is a business services company based in the United States, founded in 2008. With an employee size ranging from 201 to 500, Agios operates primarily in the research and development sector. The company focuses on advancing scientific knowledge and understanding in the field of healthcare, particularly related to thalassemia. Their published research highlights the importance of patient education and health literacy among thalassemia patients, as evidenced by a global patient survey conducted by the Thalassemia Advocacy Advisory Council, which Agios funded. This survey aimed to assess the understanding of thalassemia among patients and identified gaps in knowledge that could be addressed through enhanced educational efforts. The company collaborates with various healthcare professionals and organizations to support research initiatives and improve patient outcomes. Agios's commitment to research is reflected in their engagement with the medical community and their contributions to studies that aim to enhance the understanding of thalassemia and related conditions.